What is cell ?
cell (SCC) is a common type of keratinocytic or non-melanoma skin . It is derived from cells within the that make -the horny protein that makes up skin, and .
SCC is an invasive disease, referring to cells that have grown beyond the . SCC can sometimes metastasise (spread to distant tissues) and may prove fatal.
Intraepidermal
( SCC in situ) and mucosal SCC are considered elsewhere.
Who gets cell ?
Risk factors for SCC include:
Age and gender: SCCs are particularly prevalent in elderly males. However, they also affect females and younger adults. Previous SCC or other form of skin (basal cell , melanoma) are a strong predictor for further skin cancers. Actinic keratoses Outdoor occupation or recreation Smoking Fair skin, blue eyes and blond or red Previous injury, thermal burn, disease (eg lupus, epidermolysis bullosa, leg ) Inherited syndromes: SCC is a particular problem for families with xeroderma pigmentosum and albinism Other risk factors include ionising radiation, exposure to arsenic, and immune suppression due to disease (eg leukaemia) or medicines. Organ transplant recipients have a massively increased risk of developing SCC.
What causes cell ?
More than 90% of cases of SCC are associated with numerous DNA mutations in multiple somatic genes. Mutations in the p53 suppression gene are caused by exposure to ultraviolet radiation (UV), especially UVB (known as signature 7). Other signature mutations relate to cigarette smoking, ageing and immune suppression (eg, to drugs such as azathioprine). Mutations in signalling pathways affect epidermal receptor, RAS, Fyn, and p16INK4a signaling. 
DermNet New Zealand
Located on sun-exposed sites, particularly the face, lips, ears, hands, forearms and lower legs Size varies from a few millimetres to several centimetres in diameter. 
Types of cell
Distinct clinical types of invasive SCC include:
-the is due to excessive production of Keratoacanthoma (KA) -a rapidly growing keratinising that may resolve without treatment cuniculatum (' '), a slow-growing, on the sole of the foot. Multiple eruptive SCC/KA-like lesions arising in syndromes, such as multiple self-healing epitheliomas of Ferguson-Smith and Grzybowski
The pathologist may classify the as well differentiated, moderately well differentiated, poorly differentiated or anaplastic SCC. There are other variants. What is the treatment for advanced or metastatic cell ?
Subtypes of cell
Locally advanced primary, recurrent or metastatic SCC requires multidisciplinary consultation. Often a combination of treatments is used.
Surgery Radiotherapy Experimental targeted therapy using epidermal receptor inhibitors
Many thousands of New Zealanders are treated for SCC each year, and more than 100 die from their disease.
How can cell be prevented?
There is a great deal of evidence to show that very careful sun protection at any time of life reduces the number of SCCs. This is particularly important in ageing, sun-damaged, fair skin; in patients that are immunosuppressed; and in those who already have actinic keratoses or previous SCC.
Stay indoors or under the shade in the middle of the day Wear covering clothing Apply high protection factor SPF50+ broad-spectrum sunscreens generously to if outdoors Avoid indoor tanning (sun beds, solaria)
Oral nicotinamide (vitamin B3) in a dose of 500 mg twice daily may reduce the number and severity of SCCs in people at high risk.
Patients with multiple cell carcinomas may be prescribed an oral retinoid (acitretin or isotretinoin). These reduce the number of tumours but have some nuisance side effects.
What is the outlook for cell ?
Most SCCs are cured by treatment. Cure is most likely if treatment is undertaken when the is small. The risk of recurrence or disease-associated death is greater for tumours that are > 20 mm in diameter and/or > 2 mm in thickness at the time of surgical excision.
About 50% of people at high risk of SCC develop a second one within 5 years of the first. They are also at increased risk of other skin cancers, especially melanoma. Regular self-skin examinations and long-term annual skin checks by an experienced health professional are recommended. 
